Why diversity in clinical trials is matter of life or death
Clip: 10/30/2019 | 9m 10s
U.S. racial and ethnic diversity is ever increasing, but the medical representation of minority groups is not. A recent review of government-funded cancer research studies found that participants were disproportionately white, and fewer than 2 percent of these clinical trials focused on minorities specifically. Special correspondent Cat Wise reports on the problem and efforts to correct it.
Aired: 10/30/19Video has closed captioning.
The full episode is no longer available for online streaming. Why?
Please continue to enjoy extra(s) from this episode.
Problems Playing Video?
Major corporate funding for the PBS NewsHour is provided by BNSF, Consumer Cellular, Leidos, Babbel, and Raymond James. Funding for the PBS NewsHour Weekend is provided by Mutual of America. For a complete list of funders for the PBS NewsHour and PBS NewsHour weekend, click here.